Industry Insights

  1. Considerations To Ensure Successful Scale-up Of Single-use Processes

    Considerations to ensure successful implementation of single-use automation from laboratory-scale to large-scale production.

  2. What’s Next For Single-Use Technology In Bioprocessing

    The advantages of single-use are well-known — faster, smaller, greener, cheaper, and safer — and increasing numbers of biomanufacturers have sought to reap these benefits, especially as patent expiration and increasingly globalized manufacturing continues to change the dynamics of biomanufacturing.

  3. CDMOs — At The Core Of Next-Generation Pharma Models

    In today’s pharmaceutical industry, the economic strains of keeping a company completely vertically integrated are no longer feasible. Smaller, virtual drug companies simply do not have the resources necessary to translate a molecule to a drug product.


  4. Ensuring Barcode Accuracy From Packaging To The Patient

    Barcodes have changed very little over the last 60 years. Yet for pharmaceutical companies the barcode has taken on a vital role throughout the product’s lifecycle from original packaging to in hospital unit dose identification.

  5. How Do You Inspect Packaging Of Bottles, Cans And Cylinders?

    To ensure the package is error free, progressive companies now use automated proofreading solutions throughout the design and printing of the package and label.

  6. Changes To The Opioid Labeling Regulation

    The statistics on opioid abuse in the United States is grim. In 2014, Opioids were responsible for 28,648 deaths according to the CDC. In fact, more people died of drug abuse that year than did of motor vehicle accidents. Worldwide the statistics are not any better; it is estimated that between 26.4 million and 38 million people abuse opioids.

  7. Digitally Transforming Laboratory Operations

    “Digital transformation” is a common buzzword across industries today, but is it more than just jargon?  Faced by shifting consumer demand, rapidly evolving technology and increasing competition, organizations — to a large extent from science-based industries — are realizing that business as usual (or only incremental change to traditional approaches) does not address today’s challenges in a sustainable, long-term way.

  8. Quality By Design In Biopharma R&D: Bringing Quality Forward Pays Off

    With biologics filling the pipelines of life sciences companies more than ever, the biopharmaceutical industry needs to rethink its view of quality. Once primarily considered a focus in downstream drug development and manufacturing, quality now demands just as much attention in upstream discovery research.

  9. Can The Cloud Prevent Collaboration Failure In Biopharma?

    Working in a cloud-based information management and collaboration workspace provides a level of business agility and security that is not available with server-based, on-premises infrastructure. 

  10. A Call To Action For Pharma CMOs

    If pharmaceutical production is to be outsourced, CMOs need to be identified, contracts negotiated, and, if special capabilities are required, the CMO must examine its engineering and capital investment program. In either case, processes must be transferred and validated, and stability batches manufactured. All of this demands an extended manufacturing and supply chain planning cycle.